VKTX — Viking Therapeutics Inc. price, chart and key statistics

Price data

Price

$25.17

YTD price return

-28.45%

YTD total return

-28.45%

Next earnings

Oct 28, 2026

Market cap

2.9B2016-12 24M2026-10 2.9B+12137.5% over the window

Enterprise value

2.8B

Shares outstanding

116.7M2016-06 19.3M2026-06 116.7M+505.1% over the window

52W low

$24.94

52W high

$43.15

From 52W high

-41.67%

From 52W low

+0.92%

52W range

1%

Volume

Rel volume

1.02×

30D volume

7.4M

30D $ vol

250M

Fundamentals

EPS (ttm)

-$4.672017-03 -$0.732026-06 -$4.67+537.7% over the window

FCF (ttm)

-278.7M

FCF/share

-$2.39

Book value/share

$3.502016-06 $0.662026-06 $3.50+427.8% over the window

ROE

-130.98%2016-06 -133.8%2026-06 -131.0%-2.1% over the window

ROA

-102.47%2016-06 -92.2%2026-06 -102.5%+11.1% over the window

Current ratio

4.722016-06 3.192026-06 4.72+47.9% over the window

Growth (CAGR, ttm) · 10Y

Shares

+3.74%2025-06-30 → 2026-06-30112.4M → 116.7M (+3.7% total)+5.26%2023-06-30 → 2026-06-30100M → 116.7M (+16.6% total)+8.33%2021-06-30 → 2026-06-3078.2M → 116.7M (+49.2% total)+19.73%2016-06-30 → 2026-06-3019.3M → 116.7M (+505.1% total)

Per-share growth (CAGR, ttm) · 10Y

Book value/share

-50.54%2025-06-30 → 2026-06-30$7.07 → $3.50 (-50.5% total)-3.21%2023-06-30 → 2026-06-30$3.86 → $3.50 (-9.3% total)+4.00%2021-06-30 → 2026-06-30$2.88 → $3.50 (+21.7% total)+18.10%2016-06-30 → 2026-06-30$0.66 → $3.50 (+427.8% total)

Price

-27.54%2025-10-16 → 2026-10-16$34.73 → $25.17 (-27.5% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+32.74%2023-10-16 → 2026-10-16$10.76 → $25.17 (+133.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+33.15%2021-10-15 → 2026-10-16$6.01 → $25.17 (+318.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+36.74%2016-10-14 → 2026-10-16$1.10 → $25.17 (+2188.2% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.

Total return

-27.54%2025-10-16 → 2026-10-16$34.73 → $25.17 (-27.5% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+32.74%2023-10-16 → 2026-10-16$10.76 → $25.17 (+133.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+33.15%2021-10-15 → 2026-10-16$6.01 → $25.17 (+318.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+36.74%2016-10-14 → 2026-10-16$1.10 → $25.17 (+2188.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-5.4×2016-12 -1.482026-10 -5.49+270.2% over the window

Fwd P/E

-6.5×

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

7.2×2016-12 2.352026-10 7.19+206.3% over the window

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-9.49%

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 116.7M ÷ 112.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-3.74%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-3.74%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($3B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-3.74%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($2.9B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2016-09 -43.5%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($2.9B). Same caveat as the cash buyback yield.

0.00%2016-09 -43.5%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/B

81st